From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17‐To‐Th2 Phenotypic Transition
The Journal of Dermatology · 2026-11 · 53 (11) · 1696-1700
DOI: 10.1111/1346-8138.70478 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, online erschienen am 31.08.2026. Verfasst von Furkan Çalıcıoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kayseri Faculty of Medicine, Kayseri City Hospital, Department of Dermatology, Urticaria&Angioedema&Atopic Dermatitis Center of Reference and Excelle…. Hauptthemen laut MEDLINE: Psoriasis, Interleukins, Pruritus, Dermatitis, Atopic. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Pustular psoriasis (IL‐36/Th17) and atopic dermatitis (Th2) are associated with different but partially overlapping inflammatory pathways. Sequential expression of these phenotypes in the same patient is uncommon. We describe a 64‐year‐old woman with longstanding psoriasis vulgaris, asthma, allergic rhinitis, and a family history of atopy who developed generalized pustular psoriasis after biologic treatments. Genetic testing identified a novel, previously unreported heterozygous IL36RN frameshift variant, c.319del (p.Leu107Serfs 65). Over subsequent months, the pustular phenotype was replaced by chronic, intensely pruritic, xerotic, eczematous dermatitis fulfilling the Hanifin–Rajka criteria. Serial biopsies demonstrated mild spongiosis and an eosinophil‐rich superficial perivascular infiltrate. Risankizumab and adalimumab were temporally associated with pustular exacerbations, whereas dupilumab was followed by worsening of the eczematous phenotype without recurrent pustulation. Methotrexate 15 mg weekly, which restrains both axes, together with topical treatment was associated with sustained near‐complete clearance through Month 12. To our knowledge, this is the first report of a three‐class biologic paradox in a single patient. Sequential single‐pathway blockade in a genetically destabilized immune network may disinhibit alternative effector arms with cytokine shunting. Inborn errors of immunity should be considered in refractory inflammatory dermatoses—even in geriatric patients—and pathway‐specific biologics used cautiously when the underlying immune architecture is monogenically perturbed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kayseri Faculty of Medicine, Kayseri City Hospital, Department of Dermatology, Urticaria&Angioedema&Atopic Dermatitis Center of Reference and Excellence Clinic, Health Sciences University, Kayseri, Türkiye.
- Kayseri Faculty of Medicine, Kayseri City Hospital, Department of Medical Genetics, Health Sciences University, Kayseri, Türkiye.
- Kayseri Faculty of Medicine, Kayseri City Hospital, Department of Pathology, Health Sciences University, Kayseri, Türkiye.
ORCID-Profile: Furkan Çalıcıoğlu, Neşecan Çalıcıoğlu, Muhammet Ensar Doğan, Yücel Tekin, Ragıp Ertaş
Zitieren
APA
Çalıcıoğlu, F., Çalıcıoğlu, N., Doğan, M. E., Tekin, Y., & Ertaş, R. (2026). From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17‐To‐Th2 Phenotypic Transition. The Journal of Dermatology, 53(11), 1696-1700. https://doi.org/10.1111/1346-8138.70478
Vancouver
Çalıcıoğlu F, Çalıcıoğlu N, Doğan ME, Tekin Y, Ertaş R. From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17‐To‐Th2 Phenotypic Transition. The Journal of Dermatology. 2026;53(11):1696-1700. doi:10.1111/1346-8138.70478
BibTeX
@article{alcolu2026,
author = {Çalıcıoğlu, Furkan and Çalıcıoğlu, Neşecan and Doğan, Muhammet Ensar and Tekin, Yücel and Ertaş, Ragıp},
title = {From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17‐To‐Th2 Phenotypic Transition},
journal = {The Journal of Dermatology},
year = {2026},
volume = {53},
number = {11},
pages = {1696--1700},
doi = {10.1111/1346-8138.70478}
}
EUVIMED